Pharmacology Watch – August 1, 2015
August 1, 2015
View Issues
-
Liraglutide Helps Non-diabetics Lose Weight
The authors conclude that 3.0 mg of liraglutide given subcutaneously once daily as an adjunct to diet and exercise was associated with clinically meaningful weight loss.
-
California Mandates Vaccinations for Children
California has passed one of the strictest school vaccination laws in the country, banning the personal exemption option for school-aged children.
-
New Drug Reverses Anticoagulant Effect of Dabigatran
The authors conclude that idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes.
-
FDA Actions
The FDA issues a warning on Daytrana, approves cangrelor, signs off on a new drug to fight cystic fibrosis, and green lights a combination drug to treat heart failure.